Rocket Pharmaceuticals Inc (NASDAQ: RCKT) is -43.41% lower on its value in year-to-date trading and has touched a low of $16.21 and a high of $32.53 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RCKT stock was last observed hovering at around $17.12 in the last trading session, with the day’s loss setting it -0.16%.
Currently trading at $16.96, the stock is -11.52% and -15.25% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.33 million and changing -0.93% at the moment leaves the stock -29.79% off its SMA200. RCKT registered -12.80% loss for a year compared to 6-month loss of -33.31%. The firm has a 50-day simple moving average (SMA 50) of $19.8527 and a 200-day simple moving average (SMA200) of $24.100124.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -5.78% gain in the last 1 month and extending the period to 3 months gives it a -15.33%, and is -8.13% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.31% over the week and 6.48% over the month.
Rocket Pharmaceuticals Inc (RCKT) has around 268 employees, a market worth around $1.54B and $0.00M in sales. Distance from 52-week low is 4.62% and -47.86% from its 52-week high. The company has generated returns on investments over the last 12 months (-62.14%).
Rocket Pharmaceuticals Inc quarterly earnings per share for the current quarter are estimated at -0.76 with sales reaching $810k over the same period.The EPS is expected to grow by 0.58% this year
273.0 institutions hold shares in Rocket Pharmaceuticals Inc (RCKT), with institutional investors hold 108.21% of the company’s shares. The shares outstanding are 90.28M, and float is at 83.82M with Short Float at 13.44%. Institutions hold 104.51% of the Float.
The top institutional shareholder in the company is RTW INVESTMENTS, LP with over 17.69 million shares valued at $380.82 million. The investor’s holdings represent 18.8677 of the RCKT Shares outstanding. As of 2024-06-30, the second largest holder is WELLINGTON MANAGEMENT GROUP LLP with 9.16 million shares valued at $197.12 million to account for 9.7665 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.19 million shares representing 6.6057 and valued at over $133.33 million, while VANGUARD GROUP INC holds 6.196 of the shares totaling 5.81 million with a market value of $125.06 million.
Rocket Pharmaceuticals Inc (RCKT) Insider Activity
The most recent transaction is an insider sale by Militello John, the company’s. SEC filings show that Militello John sold 1,064 shares of the company’s common stock on Aug 16 ’24 at a price of $18.50 per share for a total of $19688.0. Following the sale, the insider now owns 51451.0 shares.
Rocket Pharmaceuticals Inc disclosed in a document filed with the SEC on Aug 16 ’24 that Patel Kinnari () sold a total of 3,989 shares of the company’s common stock. The trade occurred on Aug 16 ’24 and was made at $18.50 per share for $73812.0. Following the transaction, the insider now directly holds 0.4 million shares of the RCKT stock.
Still, SEC filings show that on Aug 16 ’24, Shah Gaurav (CEO) disposed off 9,650 shares at an average price of $18.50 for $0.18 million. The insider now directly holds 718,419 shares of Rocket Pharmaceuticals Inc (RCKT).
